A novel mechanism of retinoic acid resistance in acute promyelocytic leukemia cells through a defective pathway in telomerase regulation

Leukemia

Volumn 16, Issue 5, 2002, Pages 826-832

  Pendino, F ^a   Sahraoui, T ^a,b   Lanotte, M ^a   Segal Bendirdijian E ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b UNIVERSITY OF ORAN   (Algeria)

Author keywords

APL; Differentiation; NB4 R1SFD; Resistance; Retinoids; Telomerase; Telomeres

Indexed keywords

CELL ENZYME; MESSENGER RNA; RETINOIC ACID; RNA DIRECTED DNA POLYMERASE; TELOMERASE;

ARTICLE; CARCINOGENESIS; CELL DEATH; CELL DIFFERENTIATION; CELL IMMORTALIZATION; CELL ISOLATION; CELL MATURATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LONG TERM CARE; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN PROCESSING; REGULATORY MECHANISM; SOMATIC CELL; TELOMERE;

EID: 0036112445     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402470     Document Type: Article

References (41)

1. A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis
2. Reversing time: Origin of telomerase
3. Telomeres shortening associated with chromosomal instability in immortal cells which express telomerase activity
4. The RNA component of human telomerase
5. A mammalian telomerase-associated protein
6. Telomerase catalytic subunit homologs from fission yeast and human
7. Reconstitution of human telomerase activity in vitro
8. Activity, function, and gene regulation of the catalytic subunit of telomerase (hTERT)
9. Induction of hTERT expression and telomerase activity by estrogens in human ovary epithelium cells
10. Estrogen activates telomerase
11. Differentiation of immortal cells inhibits telomerase activity
12. Selective inhibition of telomerase activity during terminal differentiation of immortal cell lines
13. Supression of telomerase activity in HL60 cells after treatment with differentiating agents
14. Telomerase activity is repressed during differentiation of maturation-sensitive but not resistant human tumor cell lines
15. Common defects of different retinoic acid resistant promyelocytic leukemia cells are persistent telomerase activity and nuclear body disorganization
16. Down-regulation of telomerase activity is an early event of cellular differentiation without apparent telomeric DNA change
17. Suppression of telomerase reverse transcriptase (hTERT) expression in differentiated HL-60 cells: Regulatory mechanisms
18. Cellular biology and biochemistry of the retinoids
19. Retinoids in cancer therapy
20. A decade of molecular biology of retinoic acid receptors
21. Advances in the development of retinoids as chemopreventive agents
22. 13-cis-retinoic acid and interferon alpha-2a: Effective combination therapy for advanced squamous cell carcinoma of the skin
23. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia
24. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results
25. Induction of retinoic acid-binding protein in normal and malignant human myeloid cells by retinoic acid in acute promyelocytic leukemia patients
26. A retinoid-resistant acute promyelocytic leukemia subclone express a dominant negative PML-RARα mutation
27. Mutant AF-2 domain of PML-RARα in retinoic acid-resistant NB4 cells: Differentiation induced by RA is triggered directly through PML-RARα and its down-regulation in acute promyelocytic leukemia
28. Mutations in the E-domain of RARα portion of the PML-RARα chimeric gene may confer clinical resistance to all-trans retinoic acid in acute promyelocytic leukemia
29. Leukemic cellular retinoic acid resistance and missense mutations in the PML/RARα fusion gene after relapse of acute promyelocytic leukemia from treatment with all-trans retinoic acid and intensive chemotherapy
30. A mutated PML/RARα found in the retinoid maturation resistant NB4 subclone, NB4-R2, blocks RARα and wild-type PML/RARα transcriptional activities
31. NB4, a maturation inducible cell line with t(15;17) marker isolated from human acute promyelocytic leukemia (M3)
32. The t(15;17) translocation of acute promyelocytic leukemia fuses the retinoic acid receptor α gene to a novel transcribed locus
33. A retinoid acid 'resistant' t(15;17) acute promyelocytic leukemia cell line: Isolation, morphological, immunological and molecular features
34. Two distinctly regulated events, priming and triggering, during retinoid-induced maturation and resistance of NB4 promyelocytic leukemia cell line
35. Retinoids down-regulate telomerase and telomere length in a pathway distinct from leukemia cell differentiation
36. Specific association of human telomerase activity with immortal cells and cancer
37. Telomere elongation in immortal human cells without detectable telomerase activity
38. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines
39. Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts
40. Frequent amplification of the telomerase reverse transcriptase gene in human tumors
41. Differential changes of receptor (RXRα) and its RARα and PML-RARα partners induced by cAMP and retinoic acid distinguish maturation sensitive and resistant t(15;17) promyelocytic leukemia NB4 cells